KRYS RSI Chart
Last 7 days
-3.3%
Last 30 days
47.3%
Last 90 days
35.1%
Trailing 12 Months
136.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 0 | 0 | 0 | 50.7M |
2022 | 0 | 0 | 0 | 0 |
2021 | 0 | 0 | 0 | 0 |
2018 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 11, 2024 | krishnan suma | sold | -4,274,040 | 170 | -25,000 | president, r&d |
Mar 11, 2024 | krishnan krish s | sold | -4,274,040 | 170 | -25,000 | president and ceo |
Mar 11, 2024 | krishnan krish s | sold | -4,273,680 | 170 | -25,000 | president and ceo |
Mar 11, 2024 | krishnan suma | sold | -4,273,680 | 170 | -25,000 | president, r&d |
Feb 28, 2024 | krishnan krish s | acquired | - | - | 7,500 | president and ceo |
Feb 28, 2024 | krishnan krish s | sold (taxes) | -566,051 | 163 | -3,471 | president and ceo |
Feb 28, 2024 | romano kathryn | acquired | 470,270 | 63.55 | 7,400 | chief accounting officer |
Feb 28, 2024 | krishnan suma | acquired | - | - | 7,500 | president, r&d |
Feb 28, 2024 | romano kathryn | sold (taxes) | -377,367 | 163 | -2,314 | chief accounting officer |
Feb 28, 2024 | krishnan suma | sold (taxes) | -943,418 | 163 | -5,785 | president, r&d |
Which funds bought or sold KRYS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -23.81 | -9,021 | 39,699 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 1.48 | 23,765,700 | 302,182,000 | 0.01% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 147 | 35,200,600 | 56,584,500 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -0.4 | 81,609 | 1,332,900 | -% |
Feb 26, 2024 | Privium Fund Management B.V. | added | 26.87 | 221,626 | 825,986 | 0.23% |
Feb 20, 2024 | EVENTIDE ASSET MANAGEMENT, LLC | new | - | 16,932,300 | 16,932,300 | 0.28% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | added | 66.8 | 23,299,000 | 53,020,000 | 0.01% |
Feb 15, 2024 | Virtus ETF Advisers LLC | added | 3.92 | 9,896 | 98,752 | 0.06% |
Feb 15, 2024 | JANE STREET GROUP, LLC | reduced | -32.62 | -2,434,950 | 6,279,670 | -% |
Feb 15, 2024 | BARCLAYS PLC | added | 62.4 | 3,380,000 | 7,963,000 | -% |
Unveiling Krystal Biotech Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Krystal Biotech Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
Krystal Biotech Inc News
Income Statement (Quarterly) | ||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2018Q3 | 2018Q2 |
Revenue | 392.6% | 42,143,000 | 8,556,000 | - | - | - | - | - | - | - | 3,000 | 2,000 |
Operating Expenses | 12.9% | 39,005,500 | 34,549,000 | 38,048,000 | 48,823,000 | 34,770,500 | 31,451,000 | 28,753,000 | 50,222,000 | 21,876,500 | 2,972,000 | 2,449,000 |
S&GA Expenses | 4.5% | 24,764,500 | 23,697,000 | 25,904,000 | 24,035,000 | 24,029,500 | 19,935,000 | 17,863,000 | 15,908,000 | 12,867,500 | 1,058,000 | 924,000 |
R&D Expenses | 7.0% | 11,370,000 | 10,629,000 | 12,144,000 | 12,288,000 | 10,741,000 | 11,516,000 | 10,890,000 | 9,314,000 | 9,009,000 | 1,914,000 | 1,525,000 |
EBITDA Margin | - | 0.35 | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | - | - |
EBT Margin | - | 0.25 | - | - | - | - | - | - | - | - | - | - |
Net Income | -89.2% | 8,692,000 | 80,747,000 | -33,210,000 | -45,297,000 | -32,052,000 | -29,850,000 | -28,108,000 | -49,965,000 | -21,806,000 | -2,755,000 | -2,276,000 |
Net Income Margin | - | 0.22 | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | 60.5% | -9,079,000 | -23,007,000 | -36,980,000 | -31,537,000 | -27,546,000 | -33,744,000 | -59,574,000 | -32,684,000 | -61,783,000 | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 3.5% | 818 | 790 | 684 | 532 | 558 | 576 | 601 | 617 | 626 | 451 | 444 | 443 | 311 | 311 | 318 | 205 | 209 | 214 | 205 | 116 | 116 |
Current Assets | 1.0% | 588 | 582 | 484 | 355 | 384 | 398 | 429 | 438 | 442 | 346 | 370 | 406 | 275 | 288 | 299 | 188 | 196 | 204 | 196 | 108 | 113 |
Cash Equivalents | -4.0% | 358 | 373 | 276 | 141 | 162 | 186 | 219 | 269 | 341 | 287 | 330 | 402 | 268 | 282 | 292 | 180 | 188 | 195 | 187 | 98.00 | 104 |
Inventory | 32.3% | 7.00 | 5.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net PPE | -1.7% | 161 | 164 | 164 | 163 | 162 | 158 | 151 | 137 | 112 | 79.00 | 45.00 | 34.00 | 31.00 | 18.00 | 13.00 | 10.00 | 8.00 | 7.00 | 6.00 | 4.00 | 3.00 |
Liabilities | 15.4% | 40.00 | 34.00 | 31.00 | 42.00 | 36.00 | 36.00 | 42.00 | 68.00 | 33.00 | 43.00 | 25.00 | 12.00 | 19.00 | 10.00 | 8.00 | 7.00 | 6.00 | 7.00 | 7.00 | 6.00 | 3.00 |
Current Liabilities | 20.0% | 33.00 | 28.00 | 24.00 | 35.00 | 29.00 | 28.00 | 34.00 | 60.00 | 26.00 | 36.00 | 18.00 | 9.00 | 15.00 | 7.00 | 6.00 | 4.00 | 3.00 | 4.00 | 4.00 | 3.00 | 3.00 |
Shareholder's Equity | 3.0% | 779 | 756 | 653 | 490 | 522 | 541 | 559 | 549 | 594 | 408 | 419 | 431 | 292 | 302 | 310 | 198 | 203 | 208 | 198 | 109 | 113 |
Retained Earnings | 3.1% | -269 | -278 | -359 | -326 | -280 | -248 | -218 | -190 | -140 | -118 | -103 | -87.03 | -71.21 | -60.80 | -51.22 | -44.39 | -39.05 | -33.69 | -29.42 | -24.07 | -19.96 |
Additional Paid-In Capital | 1.3% | 1,048 | 1,035 | 1,013 | 816 | 804 | 791 | 780 | 741 | 735 | 527 | 522 | 518 | 363 | 363 | 361 | 243 | 242 | 241 | 228 | 134 | 133 |
Shares Outstanding | 0.1% | 28.00 | 28.00 | 28.00 | 26.00 | 26.00 | 26.00 | 25.00 | 25.00 | 22.00 | 22.00 | 22.00 | 21.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 2,800 | - | - | - | 1,400 | - | - | - | 1,200 | - | - | - | 595 | - | - | - | 454 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 65.9% | -7,232 | -21,226 | -34,190 | -26,156 | -22,329 | -19,688 | -43,059 | -15,493 | -20,900 | -7,255 | -10,129 | -9,654 | -8,024 | -6,778 | -5,054 | -6,227 | -7,000 | -4,266 | -4,209 | -3,215 | -3,518 |
Share Based Compensation | 18.5% | 9,853 | 8,312 | 11,331 | 10,437 | 9,552 | 9,059 | 8,189 | 6,430 | 5,145 | 3,666 | 4,195 | 2,313 | 570 | 1,356 | 807 | 539 | 323 | 278 | 325 | 313 | 302 |
Cashflow From Investing | -109.7% | -10,160 | 105,192 | -15,957 | 3,563 | -5,208 | -14,743 | -38,224 | -55,908 | -126,540 | -37,166 | -62,317 | -747 | -6,217 | -2,697 | -962 | -1,305 | -591 | -682 | -1,236 | -2,482 | -3,767 |
Cashflow From Financing | -80.4% | 2,619 | 13,388 | 185,269 | 1,474 | 3,069 | 2,120 | 30,700 | -542 | 202,072 | 1,508 | -199 | 144,304 | 141 | 166 | 117,469 | 243 | 299 | 13,167 | 94,019 | 40.00 | 64,288 |
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) | 12 Months Ended | ||||
---|---|---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |||
Statement of Comprehensive Income [Abstract] | |||||
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] | Product [Member] | Product [Member] | Product [Member] | ||
Product revenue, net | $ 50,699,000 | $ 0 | $ 0 | ||
Expenses | |||||
Cost, Product and Service [Extensible Enumeration] | Product [Member] | Product [Member] | Product [Member] | ||
Cost of goods sold | $ 3,094,000 | $ 0 | $ 0 | ||
Research and development | 46,431,000 | 42,461,000 | 27,884,000 | ||
Selling, general and administrative | 98,401,000 | 77,735,000 | 40,391,000 | ||
Litigation settlement | 12,500,000 | 25,000,000 | 0 | ||
Total operating expenses | 160,426,000 | 145,196,000 | 68,275,000 | ||
Loss from operations | (109,727,000) | (145,196,000) | (68,275,000) | ||
Other income (expense) | |||||
Gain from sale of priority review voucher | 100,000,000 | 0 | 0 | ||
Interest and other income, net | 22,624,000 | 5,221,000 | 197,000 | ||
Interest expense | 0 | 0 | (1,492,000) | ||
Income (loss) before income taxes | 12,897,000 | (139,975,000) | (69,570,000) | ||
Income tax expense | (1,965,000) | 0 | 0 | ||
Net income (loss) | 10,932,000 | (139,975,000) | (69,570,000) | ||
Unrealized income (loss) on available-for-sale securities and other | [1] | 1,366,000 | (565,000) | (169,000) | |
Comprehensive income (loss) | $ 12,298,000 | $ (140,540,000) | $ (69,739,000) | ||
Net income (loss) per common share: | |||||
Net income (loss) per common share: basic (in usd per share) | $ 0.40 | $ (5.49) | $ (3.13) | ||
Net income (loss) per common share: diluted (in usd per share) | $ 0.39 | $ (5.49) | $ (3.13) | ||
Weighted-average common shares outstanding: | |||||
Weighted-average common shares outstanding: basic (in shares) | 27,154,190 | 25,491,721 | 22,196,846 | ||
Weighted-average common shares outstanding: diluted (in shares) | 27,751,809 | 25,491,721 | 22,196,846 | ||
|
Consolidated Balance Sheets - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 358,328,000 | $ 161,900,000 |
Short-term investments | 173,850,000 | 217,271,000 |
Accounts receivable, net | 42,040,000 | 0 |
Inventory | 6,985,000 | 0 |
Prepaid expenses and other current assets | 6,706,000 | 4,608,000 |
Total current assets | 587,909,000 | 383,779,000 |
Property and equipment, net | 161,202,000 | 161,684,000 |
Long-term investments | 61,954,000 | 4,621,000 |
Right-of-use assets | 7,027,000 | 8,042,000 |
Other non-current assets | 263,000 | 324,000 |
Total assets | 818,355,000 | 558,450,000 |
Current liabilities | ||
Accounts payable | 4,132,000 | 3,981,000 |
Current portion of lease liability | 1,474,000 | 1,561,000 |
Accrued expenses and other current liabilities | 27,488,000 | 23,305,000 |
Total current liabilities | 33,094,000 | 28,847,000 |
Lease liability | 6,620,000 | 7,372,000 |
Total liabilities | 39,714,000 | 36,219,000 |
Commitments and contingencies (Note 7) | ||
Stockholders' equity | ||
Common stock; $0.00001 par value; 80,000,000 shares authorized at December 31, 2023 and 2022; 28,236,673 and 25,763,743 shares issued and outstanding at December 31, 2023 and 2022, respectively | 0 | 0 |
Additional paid-in capital | 1,047,830,000 | 803,718,000 |
Accumulated other comprehensive gain (loss) | 638,000 | (728,000) |
Accumulated deficit | (269,827,000) | (280,759,000) |
Total stockholders' equity | 778,641,000 | 522,231,000 |
Total liabilities and stockholders' equity | $ 818,355,000 | $ 558,450,000 |